Cargando…

A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients

PURPOSE: In recurrent prostate carcinoma, determination of the site of recurrence is crucial to guide personalized therapy. In contrast to prostate-specific membrane antigen (PSMA)–positron emission tomography (PET) imaging, computed tomography (CT) has only limited capacity to detect lymph node met...

Descripción completa

Detalles Bibliográficos
Autores principales: Peeken, Jan C., Shouman, Mohamed A., Kroenke, Markus, Rauscher, Isabel, Maurer, Tobias, Gschwend, Jürgen E., Eiber, Matthias, Combs, Stephanie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680305/
https://www.ncbi.nlm.nih.gov/pubmed/32468251
http://dx.doi.org/10.1007/s00259-020-04864-1
_version_ 1783612430894497792
author Peeken, Jan C.
Shouman, Mohamed A.
Kroenke, Markus
Rauscher, Isabel
Maurer, Tobias
Gschwend, Jürgen E.
Eiber, Matthias
Combs, Stephanie E.
author_facet Peeken, Jan C.
Shouman, Mohamed A.
Kroenke, Markus
Rauscher, Isabel
Maurer, Tobias
Gschwend, Jürgen E.
Eiber, Matthias
Combs, Stephanie E.
author_sort Peeken, Jan C.
collection PubMed
description PURPOSE: In recurrent prostate carcinoma, determination of the site of recurrence is crucial to guide personalized therapy. In contrast to prostate-specific membrane antigen (PSMA)–positron emission tomography (PET) imaging, computed tomography (CT) has only limited capacity to detect lymph node metastases (LNM). We sought to develop a CT-based radiomic model to predict LNM status using a PSMA radioguided surgery (RGS) cohort with histological confirmation of all suspected lymph nodes (LNs). METHODS: Eighty patients that received RGS for resection of PSMA PET/CT-positive LNMs were analyzed. Forty-seven patients (87 LNs) that received inhouse imaging were used as training cohort. Thirty-three patients (62 LNs) that received external imaging were used as testing cohort. As gold standard, histological confirmation was available for all LNs. After preprocessing, 156 radiomic features analyzing texture, shape, intensity, and local binary patterns (LBP) were extracted. The least absolute shrinkage and selection operator (radiomic models) and logistic regression (conventional parameters) were used for modeling. RESULTS: Texture and shape features were largely correlated to LN volume. A combined radiomic model achieved the best predictive performance with a testing-AUC of 0.95. LBP features showed the highest contribution to model performance. This model significantly outperformed all conventional CT parameters including LN short diameter (AUC 0.84), LN volume (AUC 0.80), and an expert rating (AUC 0.67). In lymph node–specific decision curve analysis, there was a clinical net benefit above LN short diameter. CONCLUSION: The best radiomic model outperformed conventional measures for detection of LNM demonstrating an incremental value of radiomic features. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00259-020-04864-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7680305
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-76803052020-11-23 A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients Peeken, Jan C. Shouman, Mohamed A. Kroenke, Markus Rauscher, Isabel Maurer, Tobias Gschwend, Jürgen E. Eiber, Matthias Combs, Stephanie E. Eur J Nucl Med Mol Imaging Original Article PURPOSE: In recurrent prostate carcinoma, determination of the site of recurrence is crucial to guide personalized therapy. In contrast to prostate-specific membrane antigen (PSMA)–positron emission tomography (PET) imaging, computed tomography (CT) has only limited capacity to detect lymph node metastases (LNM). We sought to develop a CT-based radiomic model to predict LNM status using a PSMA radioguided surgery (RGS) cohort with histological confirmation of all suspected lymph nodes (LNs). METHODS: Eighty patients that received RGS for resection of PSMA PET/CT-positive LNMs were analyzed. Forty-seven patients (87 LNs) that received inhouse imaging were used as training cohort. Thirty-three patients (62 LNs) that received external imaging were used as testing cohort. As gold standard, histological confirmation was available for all LNs. After preprocessing, 156 radiomic features analyzing texture, shape, intensity, and local binary patterns (LBP) were extracted. The least absolute shrinkage and selection operator (radiomic models) and logistic regression (conventional parameters) were used for modeling. RESULTS: Texture and shape features were largely correlated to LN volume. A combined radiomic model achieved the best predictive performance with a testing-AUC of 0.95. LBP features showed the highest contribution to model performance. This model significantly outperformed all conventional CT parameters including LN short diameter (AUC 0.84), LN volume (AUC 0.80), and an expert rating (AUC 0.67). In lymph node–specific decision curve analysis, there was a clinical net benefit above LN short diameter. CONCLUSION: The best radiomic model outperformed conventional measures for detection of LNM demonstrating an incremental value of radiomic features. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00259-020-04864-1) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-05-28 2020 /pmc/articles/PMC7680305/ /pubmed/32468251 http://dx.doi.org/10.1007/s00259-020-04864-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Peeken, Jan C.
Shouman, Mohamed A.
Kroenke, Markus
Rauscher, Isabel
Maurer, Tobias
Gschwend, Jürgen E.
Eiber, Matthias
Combs, Stephanie E.
A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients
title A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients
title_full A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients
title_fullStr A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients
title_full_unstemmed A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients
title_short A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients
title_sort ct-based radiomics model to detect prostate cancer lymph node metastases in psma radioguided surgery patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680305/
https://www.ncbi.nlm.nih.gov/pubmed/32468251
http://dx.doi.org/10.1007/s00259-020-04864-1
work_keys_str_mv AT peekenjanc actbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT shoumanmohameda actbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT kroenkemarkus actbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT rauscherisabel actbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT maurertobias actbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT gschwendjurgene actbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT eibermatthias actbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT combsstephaniee actbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT peekenjanc ctbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT shoumanmohameda ctbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT kroenkemarkus ctbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT rauscherisabel ctbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT maurertobias ctbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT gschwendjurgene ctbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT eibermatthias ctbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients
AT combsstephaniee ctbasedradiomicsmodeltodetectprostatecancerlymphnodemetastasesinpsmaradioguidedsurgerypatients